image description

Krishna Veeraraghavan

Partner

Krishna Veeraraghavan

Partner
New York +1-212-558-4000+1-212-558-4000 +1-212-558-3588+1-212-558-3588
veeraraghavank@sullcrom.com

Recognized as “Dealmaker of the Week” by The American Lawyer in May 2015 for Synageva’s pending $8.4 billion acquisition by Alexion and in November 2014 for LabCorp’s $6.1 billion acquisition of Covance, for his work on M&A mega-deals by The Legal 500 and as Leading Lawyer by the IFLR1000, Krishna Veeraraghavan is a partner and member of S&C’s Mergers and Acquisitions Group, focusing his practice on M&A, corporate governance and private equity matters. He has represented U.S. and non-U.S. companies, special committees, boards of directors and financial advisers in public company transactions, leveraged buyouts and private company sales of subsidiaries and divisions. He is an adjunct professor at Columbia Law School.

Publications

  • “Merger Market Perspective: Opportunities and Legal Issues in FinTech M&A,” FinTech Law Report (co-author)
  • “The Continuing Importance of Process in Entire Fairness Review: In re Nine Systems,” Deal Lawyers (co-author)
  • “Model Provision for Merger Agreement (Tender Offer),” Practical Law: The Journal (co-author)
  • “The Proxy Put and Fiduciary Duties: A Closer Look at Kallick v. SandRidge,” The M&A Lawyer (co-author)
  • “The Uncertain Relationship Between Fiduciary Waivers & the Implied Covenant of Good Faith in Delaware Alternative Entity Law,” The M&A Lawyer (co-author)
  • “Using Option Structures to Reduce Buyer Risk in Pharmaceutical M&A Deals,” Practical Law Company practice note (co-author)
  • “Qualitative Disclosure & Financial Projects: Overshadowed Lessons from In re Ancestry.com,” Columbia Law School’s Blue Sky Blog (co-author)
  • “Confidentiality Agreements: Lessons from Delaware,” Bloomberg Law – Practitioner Contributions (co-author)
  • “Recent Delaware Developments: Three Cases with Surprising Outcomes that Reinforce Traditional Fiduciary Principles,” Columbia Law School’s Blue Sky Blog (co-author)
  • “What You Need to Know Before You Receive an Unsolicited Bid,” The M&A Lawyer (co-author)
  • “Memo to the Board of Directors: Preparing for 2013,” Bloomberg/BNA’s Corporate Accountability Report (co-author)
  • “Preparing and Disclosing Financial Projections in Public M&A,” Practical Law: The Journal (co-author)
  • “FCPA for Dealmakers: A Tutorial,” The Deal Pipeline (co-author)
  • “What You Need to Know About the FCPA Before You Do Your Next Deal,” The M&A Lawyer (co-author)

Rankings and Recognitions

  • The American Lawyer – Recognized as Dealmaker of the Week for Synageva’s $8.4 billion acquisition by Alexion (May 2015)
  • The American Lawyer – Recognized as Dealmaker of the Week for LabCorp’s $6.1 billion acquisition of Covance (November 2014)
  • The Legal 500 United States – Recognized for M&A: Mega-Deals ($5BN+) (2014)
  • IFLR1000 – Recognized as a Leading Lawyer (2013, 2014, 2015)
  • M&A Advisor – Named an M&A Advisor Award Finalist for "Legal Advisor of the Year" (2013)
  • New York Super Lawyers – Recognized as a Super Lawyer for Mergers & Acquisitions, Corporate Governance and Compliance, and Business/Corporate (2013, 2014)
  • Law360 – Winner, Life Sciences Group Of The Year: Sullivan & Cromwell (2015)
  • The American Lawyer – Named a finalist for Transatlantic Rising Stars (Lawyers Under 40) (May 2015)
  • New York Law Journal - Recognized as a Rising Star (2015)
  • Selected as one of National Asian Pacific American Bar Association’s (NAPABA) "Best Lawyers Under 40" (2014)
  • M&A Advisor – Recognized in “40 Under 40” ranking of 40 top professionals who have reached a significant level of success in their careers under the age of 40. (March 2012)
  • Law360 – Recognized as a Rising Star for Mergers & Acquisitions (2014, 2015)
  • Diversity & the Bar – Recognized as one of four Rising Stars by the Minority Corporate Counsel Association (MCCA) (March/April 2013)
  • New York Super Lawyers – Recognized as a Rising Star for Mergers & Acquisitions, Corporate Governance and Compliance, and Business/Corporate (2011, 2012, 2013, 2014)

Speaking Engagements

  • Co-presenter, “The Art of Negotiation,” Deallawyers.com
  • Co-presenter, “M&A Non-Disclosure Agreements: Drafting and Key Issues that Can Affect the Course of a Deal,” Practising Law Institute webcast
  • Co-presenter, “Preparing and Disclosing Financial Projections in Public M&A,” Practising Law Institute’s Securities Law Practice Center
  • Co-presenter, “FCPA Due Diligence in Cross-Border Transactions,” Practising Law Institute’s “Hot Topic” briefing
  • Conference Co-Chairman, “Best Practices in Due Diligence: Addressing Due Diligence Challenges in a Rapidly Changing Global M&A Environment,” Executive Enterprise Institute

Professional Activities and Community Involvement

  • American Bar Association – Committee on Mergers and Acquisitions
  • American India Foundation – Board of Trustees
  • Columbia Law School – Adjunct Professor
  • Columbia Law School’s Blue Sky Blog – Advisory Board
  • Columbia Law School – Steering Committee of the Board of Visitors
  • Leadership Council on Legal Diversity (LCLD) – 2013 Fellow
  • South Asian Youth Action (SAYA!) – Board of Directors


SELECTED REPRESENTATIONS

In Healthcare & Life Sciences:
  • Amgen in its $315 million acquisition of KAI Pharmaceuticals
  • Cyberonics in its $3.3 billion pending merger with Sorin S.p.A.
  • Concordia Healthcare in its $1.2 billion acquisition of Covis
  • Eastman Kodak in the $2.55 billion sale of its health segment business to Onex Corporation
  • Senior management in connection with the $33 billion leveraged buyout of HCA by a consortium of private equity funds
  • Centerview Partners, as financial adviser to Hyperion Therapeutics in its $1.1 billion acquisition by Horizon Pharma
  • Idenix Pharmaceuticals in its $3.85 billion acquisition by Merck
  • Impax Laboratories in its $700 million acquisition of CorePharma LLC
  • IMS in its $5.2 billion sale to investment funds managed by TPG Capital and Canada Pension Plan Investment Board
  • Centerview Partners, as financial adviser to InterMune in its $8.3 billion acquisition by Roche
  • LabCorp in its approximately $6.1 billion acquisition of Covance
  • Perrigo Company in its approximately $8.6 billion acquisition of Elan Pharmaceuticals
  • Pharmasset in its $11 billion acquisition by Gilead Sciences
  • Royal Philips in its $5.1 billion acquisition of Respironics
  • Synageva BioPharma in its $8.4 billion pending acquisition by Alexion Pharmaceuticals
In Technology, Media & Telecommunications:
  • AT&T in its
    • $780 million acquisition of Atlantic Tele-Network’s domestic retail wireless business;
    • $950 million sale of AT&T Advertising Solutions and AT&T Interactive to an affiliate of  Cerberus Capital Management; and
    • $2.35 billion acquisition of  certain wireless assets from Verizon Wireless; and its related  $240 million sale of certain wireless assets to Verizon Wireless.
  • Cablevision in its $500 million acquisition of the Sundance Channel
  • Eastman Kodak in the $527 million sale of its digital imaging patent portfolio to a consortium organized by Intellectual Ventures and RPX Corporation
  • Harris in its $525 million acquisition of CapRock Communications
  • Amazon.com, CSG Systems International, CA Technologies, ScanSource, SS&C Technologies, and Telstra Corporation in connection with various corporate matters
In Energy:
  • BHP Billiton in its $15.1 billion acquisition of Petrohawk Energy
  • Constellation Energy in the sale of its downstream natural gas unit to Macquarie Group
  • Dynegy in its proposed acquisition by The Blackstone Group and Icahn Enterprises, respectively
  • UBS in the sale of its Canadian-based commodities energy business and global agricultural commodities business to J.P. Morgan
In Consumer & Retail and Industrials:
  • Anheuser-Busch InBev
    • in connection with Constellation Brands’s  $300 million acquisitions of Anheuser-Busch InBev’s Meixcan glass production plant;
    • $20.1 billion acquisition of the remaining  stake in Grupo Modelo;
    • $2.9 billion sale of Compañía Cervecera de Coahuila to Constellation Brands;
    • $1.85 billion sale of a 50% interest in Crown Imports to Constellation Brands; and
    • $2.7 billion sale of its entertainment parks business to an affiliate of Blackstone.
  • Coleman Cable in its $786 million acquisition by Southwire
  • The Heyman Family in its $3.2 billion sale of International Specialty Products (ISP) to Ashland
  • Lion Capital in its
    • acquisition of Spence Diamonds; and
    • pending  $1.51 billion acquisition of Bumble Bee Foods acquisition by Thai Union Frozen Products Public Company Limited.
  • NBTY in its $4 billion acquisition by The Carlyle Group
  • The transactions committee of PepsiAmericas in PepsiAmericas’ $2 billion acquisition by PepsiCo
  • Praxair in its $1.1 billion acquisition of NuCO2
  • Royal Philips in its $2.7 billion acquisition of The Genlyte Group
  • RR Donnelley & Sons Co. in its $620 million acquisition of Consolidated Graphics
In Real Estate:
  • Highgate Hotels L.P. in its minority interest investment by Trilantic Capital Partners
  • Whitehall in its $2.2 billion acquisition of Equity Inns
  • NorthStar Realty Finance Corp in connection with various corporate matters